Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Top Stories; semaglutide; GLP-1 medicines; iDexis; Sahpra; South African Pharmacy Council; Novo Nordisk; pharmaceutical regulation

11.09.2026

Compounded semaglutide appeal dismissed

A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.

Search the archive

Browse by month

Archives